K Number
K963500
Device Name
GLUCOMETER DEX DIABETES CARE SYSTEM
Manufacturer
Date Cleared
1997-01-21

(140 days)

Product Code
Regulation Number
862.1345
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The GLUCOMETER DEX Diabetes Care System is for the self-monitoring of blood glucose as an adjunct to the care of persons with diabetes.
Device Description
The GLUCOMETER DEX Diabetes Care System consists of the GLUCOMETER® DEX™ Blood Glucose Meter; GLUCOMETER® DEX™ Blood Glucose Test Sensor Disc; and the GLUCOMETER® DEX™ Controls (Normal, Low and High). The GLUCOMETER DEX Diabetes Care System is an over-the-counter (OTC) home test for glucose in blood. It is for use by persons with diabetes and by healthcare professionals in home settings and in healthcare facilities.
More Information

Not Found

Not Found

No
The summary describes a standard blood glucose monitoring system and does not mention any AI or ML components or capabilities.

No.
The device is a glucometer used for monitoring blood glucose levels, which helps in managing diabetes, but it does not directly treat the condition.

Yes
The device is used for "self-monitoring of blood glucose as an adjunct to the care of persons with diabetes," which implies it provides information used to aid in the diagnosis, treatment, or prevention of disease. The "Summary of Performance Studies" also states that "users can obtain blood glucose results," which is a diagnostic output.

No

The device description explicitly lists hardware components: a blood glucose meter, test sensor disc, and controls.

Yes, this device is an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for "self-monitoring of blood glucose as an adjunct to the care of persons with diabetes." This involves testing a biological sample (blood) outside of the body to provide information for medical purposes (managing diabetes).
  • Device Description: The system includes a "Blood Glucose Test Sensor Disc" and "Controls," which are components used to perform a test on a biological sample.
  • Nature of the Test: Measuring blood glucose is a classic example of an in vitro diagnostic test. It analyzes a component of the blood to provide diagnostic or monitoring information.

The description clearly indicates that the device is used to perform a test on a biological sample (blood) outside of the body to provide information related to a medical condition (diabetes). This aligns with the definition of an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

The GLUCOMETER DEX Diabetes Care System is for the self-monitoring of blood glucose as an adjunct to the care of persons with diabetes.*

Product codes

75 CGA

Device Description

The GLUCOMETER DEX Diabetes Care System consists of the GLUCOMETER® DEX™ Blood Glucose Meter; GLUCOMETER® DEX™ Blood Glucose Test Sensor Disc; and the GLUCOMETER® DEX™ Controls (Normal, Low and High). The GLUCOMETER DEX Diabetes Care System is an over-the-counter (OTC) home test for glucose in blood. It is for use by persons with diabetes and by healthcare professionals in home settings and in healthcare facilities.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

persons with diabetes and by healthcare professionals in home settings and in healthcare facilities.

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

The performance of the GLUCOMETER DEX Diabetes Care System was studied in-house and in clinical settings by healthcare professionals and by persons with diabetes. The studies demonstrated that users can obtain blood glucose results that are substantially equivalent to current methods for blood glucose.

Key Metrics

Not Found

Predicate Device(s)

GLUCOMETER ELITE® Blood Glucose Monitoring System, YSI Model 2300 STAT Plus Analyzer, ACA® Discrete Clinical Analyzer, Hitachi 704 chemistry analyzer, Hitachi 747 chemistry analyzer

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 862.1345 Glucose test system.

(a)
Identification. A glucose test system is a device intended to measure glucose quantitatively in blood and other body fluids. Glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus, neonatal hypoglycemia, and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.(b)
Classification. Class II (special controls). The device, when it is solely intended for use as a drink to test glucose tolerance, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

0

K9163500

JAN 2 | 1997

:

page 1 of 2

이 대한민국 대학교 대학교 대학교

510(k) SAFETY AND EFFECTIVENESS SUMMARY

Prepared:August 30, 1996
Submitter:Bayer Corporation, Business Group Diagnostics
Address:1884 Miles Avenue, P. O. Box 70
Elkhart, IN 46515
(219) 262-6929
Contact:Rosanne M. Savol, R.A.C.
Manager, Regulatory Affairs
Device:Trade/Proprietary Name: GLUCOMETER® DEX™ Diabetes Care System
Common/Usual Name: Test for glucose in blood
Blood glucose meter
Control material
Document Control Number: K96 _______
Classification:Division of Clinical Laboratory Devices
Panel - Clinical Chemistry and Toxicology
Classification Code - 75 CGA (Glucose Oxidase, Glucose)
Predicate Devices:GLUCOMETER ELITE® Blood Glucose Monitoring System;
YSI Model 2300 STAT Plus Analyzer; ACA® Discrete Clinical
Analyzer; Hitachi 704 chemistry analyzer; Hitachi 747 chemistry analyzer.
Device Description:The GLUCOMETER DEX Diabetes Care System consists of the
GLUCOMETER® DEX™ Blood Glucose Meter;
GLUCOMETER® DEX™ Blood Glucose Test Sensor Disc; and
the GLUCOMETER® DEX™ Controls (Normal, Low and High).
The GLUCOMETER DEX Diabetes Care System is an over-the-
counter (OTC) home test for glucose in blood. It is for use by
persons with diabetes and by healthcare professionals in home
settings and in healthcare facilities.

1

Bayer Corporation, Business Group Diagnostics
GLUCOMETER® DEX™ Diabetes Care System S&E Summary page 2 of 2

:

이 대한민국 대학교 대학교

| Intended Use: | The GLUCOMETER DEX Diabetes Care System is for the self-
monitoring of blood glucose as an adjunct to the care of persons
with diabetes.* |
|-----------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Technological
Characteristics: | The GLUCOMETER DEX Diabetes Care System employs an
amperometric glucose oxidase method to measure glucose in
blood. It is conceptually the same as other blood glucose
monitoring products available for blood glucose testing. The test
sensor discs are individually sealed in a package of ten. Blood
glucose results are referenced to plasma glucose. The System has
a linear response to glucose from 10 - 600 mg/dL. |
| Assessment of
Performance: | The performance of the GLUCOMETER DEX Diabetes Care
System was studied in-house and in clinical settings by healthcare
professionals and by persons with diabetes. The studies
demonstrated that users can obtain blood glucose results that are
substantially equivalent to current methods for blood glucose. |
| Conclusion: | The results of in-house and clinical evaluations of the
GLUCOMETER DEX Diabetes Care System demonstrate that
the device is equivalent in performance to the predicate devices
and suitable for its intended use. |

. ... ..............................................................................................................................................................................

،

!

:

  • "Consensus Statement on Self-Monitoring of Blood Glucose," Diabetes Care, Vol. 10, No. 1, January-February 1987, pp. 95-99.